Dissolving stent could spare patients a second procedure
NCT ID NCT04708288
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study follows about 200 people who receive a special stent that naturally dissolves over time to open blocked bile or pancreatic ducts. The stent is designed to avoid the need for a second procedure to remove it. Researchers track safety and how well the stent keeps the duct open during routine care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ARCHIMEDES Biodegradable Biliary and Pancreatic Stent
What this could lead to
If successful, this biodegradable stent could offer a safer, temporary way to open blocked ducts without needing a second procedure to remove it.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Risks include pancreatitis, bleeding, infection, or stent migration.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTED BILIARY AND PANCREATIC DUCT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AUSL Romagna Ospedale Morgagni - Pierantoni
COMPLETEDForlì, 47121, Italy
-
Emek Medical Center
COMPLETEDAfula, 1834111, Israel
-
Endoscopy Unit, Humanitas Research Hospital
ACTIVE_NOT_RECRUITINGRozzano, Milano, 20089, Italy
-
Evangelisches Krankenhaus Düsseldorf
RECRUITINGDüsseldorf, 40217, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Gastroenterology and Digestive Endoscopy Unit Fondazione I.R.C.C.S. Policlinico San Matteo
ACTIVE_NOT_RECRUITINGPavia, 27100, Italy
-
HUS Helsinki University Hospital
COMPLETEDHelsinki, 00290, Finland
-
Hospital Universitario de Salamanca
RECRUITINGSalamanca, 37007, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Européen Georges-Pompidou HEGP Service d'Hépato-gastro-entérologie et endoscopies digestives
ACTIVE_NOT_RECRUITINGParis, 75015, France
-
Tan Tock Seng Hospital Pte Ltd,
COMPLETEDSingapore, 308433, Singapore
-
UCBM - Campus Bio-Medico University
ACTIVE_NOT_RECRUITINGRoma, 00128, Italy
-
University Medical Center Ljubljana
RECRUITINGLjubljana, 1000, Slovenia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••